Clintrex

What Clintrex does

Clintrex (legal entity Clintrex Research LLC) is a privately-held clinical research consulting company founded in 2008 that operationalizes CNS drug development pathways for pharmaceutical and biotech sponsors. The firm delivers an integrated suite of services spanning pre-clinical development, clinical trial design and execution, regulatory strategy (FDA, EMA, Health Canada, Japanese FDA), biostatistics, medical writing, business development/due diligence, and fractional CMO engagements. Its differentiator is disease-specific expertise concentrated in neurodegenerative disorders (Alzheimer's, Parkinson's, Huntington's), multiple sclerosis, epilepsy, and migraine, delivered via a proprietary SMART CLINICAL TRIALS methodology designed to minimize variability, enable smaller sample sizes, and improve signal detection.

The company engages clients through four flexible models — Extended Encounter (full-day in-person), Telephone Encounter (1–2 hour focused calls), On-Going Monthly Services (monthly retainer), and Milestone-Based Projects — with quote-based pricing. Clintrex has served 150+ pharma and biotech companies, reports a 60%+ repeat-engagement rate, and its principals are credited on 100+ pivotal trials leading to CNS therapy approvals across the US, Europe, and Japan. The leadership bench is unusually concentrated in ex-FDA neurology regulators and internationally-cited KOLs. Following a 2025 acquisition, Clintrex now operates as a division of Tox Strategies within the BlueRidge Life Sciences (BRLS) umbrella, which also includes EpidStrategies, 21st Century Toxicology, HEOR Strategies, Modality Solutions, and Suttons Creek, enabling cross-sell of an integrated non-clinical-to-commercial development stack.

Name

Clintrex

Legal name

Clintrex Research LLC

Website

https://clintrex.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Clintrex is a CNS-focused clinical research consulting firm that provides pre-clinical, clinical trial design, regulatory, biostatistical, and CMO services to pharmaceutical and biotech sponsors developing neurodegenerative and neurological therapies. Now a division of BlueRidge Life Sciences.

Ownership category

akta.pro rank

Product category

Clinical Research Consulting Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Testing, Inspection, Certification & Commissioning (TICx) Technical Services (BPAHAIAL)

akta.pro secondary industry

Liver & GI Clinical Research (Trials Centers) (HLAKAEAL)

Keywords

• Clinical research consulting
• CNS drug development
• Regulatory strategy services
• Clinical trial design
• Pharmaceutical advisory

Headquarters

HQ city

Sarasota

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Consulting Services: Provides clinical, regulatory, and business development consulting services under various engagement models: Extended Encounter (full-day in-person meetings), Telephone Encounter (1-2 hour focused calls), On-Going Monthly Services (monthly fee for ongoing support), and Milestone Based Projects (individual project work). Services span pre-clinical, clinical trial design/execution, regulatory strategy, and medical writing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Clintrex is a clinical research consulting company that works with pharmaceutical and biotech organizations to operationalize development pathways for new treatments for CNS diseases. It provides an integrated suite of advisory services spanning pre-clinical development, clinical trial design and execution, regulatory strategy, biostatistics, medical writing, due diligence, and fractional CMO support, delivered through disease-specific experts applying its proprietary SMART CLINICAL TRIALS methodology.

Product overview

Clintrex is a clinical research consulting company operating as a division of BlueRidge Life Sciences (BRLS). The company offers an integrated suite of advisory and operational services for pharmaceutical organizations developing treatments for CNS diseases, particularly neurodegenerative disorders (Alzheimer's, Parkinson's, Huntington's), MS, epilepsy, and migraine. Clintrex provides a comprehensive service portfolio organized into distinct offerings: Pre-Clinical Development, Clinical Development Plan, Clinical Trial Design and Execution, Regulatory Support/Strategy, Medical Writing, Business Development/Due Diligence, and CMO Services. The company also operates a proprietary SMART Clinical Trials methodology. Clintrex engages with clients through flexible engagement models including The Clintrex Encounter (extended in-person), Telephone Encounter (focused calls), On-Going Monthly Services, and Milestone-Based Projects. As part of BlueRidge Life Sciences, Clintrex collaborates with sister divisions including EpidStrategies (epidemiology), 21CT (toxicology), HEOR Strategies (health economics), Modality Solutions (cold chain engineering), and Suttons Creek (combination products/regulatory affairs).

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-Clinical Development

Quantifiable outcome

• 60%+ client return rate from 150+ pharmaceutical and biotech companies served

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• BlueRidge Life Sciences (BRLS)coreStrategic or Co-development PartnerClintrex operates as a division of BlueRidge Life Sciences, an umbrella organization that brings together multiple specialized life sciences consulting companies. BRLS also includes EpidStrategies, 21st Century Toxicology, HEOR Strategies, Modality Solutions, and Suttons Creek, offering clients comprehensive expertise across non-clinical and clinical development.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO with a long-standing specialization in CNS clinical research, including neuroscience, neurodegenerative disorders, and pain. Competes with Clintrex for the same biotech and pharma CNS development engagements and is the most direct specialty competitor.
• Premier Research: Specialty CRO with deep CNS and rare-disease focus, offering clinical trial design, regulatory strategy, and biostatistics. Clintrex's VP Operations previously held senior roles at SCIREX, which became Premier Research, making the two direct competitors for similar CNS engagements.
• Veristat: Clinical research organization focused on clinical trial design, biostatistics, regulatory affairs, and medical writing for complex therapeutic areas. Targets the same biotech sponsor profile and competes for regulatory and statistical work that Clintrex also delivers.
• Rho: Contract research organization with strengths in clinical operations, regulatory strategy, biostatistics, and medical writing across multiple therapeutic areas including CNS. Offers integrated services comparable to Clintrex's Clinical Development and Regulatory Support offerings.
• Ergomed Group: Specialized CRO with significant CNS and orphan-disease experience, providing clinical trial management, biostatistics, and pharmacovigilance. Competes with Clintrex for neurology-focused biotech sponsors seeking boutique-style service with global delivery.
• Celerion: Early-stage clinical research services provider with expertise in clinical pharmacology, Phase 1 design, and biostatistics relevant to CNS programs. Comparable to Clintrex on the clinical design and biostatistical advisory side of CNS development.
• Cato Research: Boutique clinical and regulatory consulting firm providing clinical trial design, regulatory strategy, and drug development support to biotech and pharma sponsors. Closely comparable in size, scope, and target customer to Clintrex's regulatory and clinical development consulting.

Broad incumbents

• Medpace: Full-service mid-to-large CRO with strong CNS and metabolic therapeutic area expertise. Competes with Clintrex for biotech CNS sponsors but offers broader global operational scale; Clintrex often partners with or complements Medpace via the CRO oversight engagement model.
• Charles River Laboratories: Large CRO and preclinical services provider with a CNS and rare-disease research portfolio. Overlaps with Clintrex's clinical and regulatory advisory services but at much larger scale and broader therapeutic coverage, including through its BRLS-style integrated offerings.
• IQVIA: Largest global CRO and clinical research services provider with substantial CNS and neuroscience capabilities. Competes for large enterprise CNS engagements and provides technology-enabled operational scale that exceeds Clintrex's boutique model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clintrex

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clintrex